Li‐Qiang Sun

Preclinical Profile and Characterization of the Hepatitis C Virus NS3 Protease Inhibitor Asunaprevir (BMS-650032)

Fiona McPhee, Amy K. Sheaffer, Jacques Friborg et al. · Antimicrobial Agents and Chemotherapy · 2012 · 183 citations · Full text

The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Paul M. Scola, Li‐Qiang Sun, Alan Xiangdong Wang et al. · Journal of Medicinal Chemistry · 2014 · 109 citations

Identification of a More Potent Analogue of the Naturally Occurring Alkaloid Huperzine A. Predictive Molecular Modeling of Its Interaction with AChE

Alan P. Kozikowski, Giuseppe Campiani, Li‐Qiang Sun et al. · Journal of the American Chemical Society · 1996 · 106 citations

Synthesis and structure–activity relationship of novel benzoxazole derivatives as melatonin receptor agonists

Li‐Qiang Sun, Jie Chen, Marc A. Bruce et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 88 citations · Full text

Structure–activity Relationship, Molecular Pharmacology, Melatonin Receptor Agonists +8

Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection

Paul M. Scola, Alan Xiangdong Wang, Andrew C. Good et al. · Journal of Medicinal Chemistry · 2014 · 66 citations · Full text